Genetic variants in m5C modification coding genes were associated with enhanced pediatric ALL susceptibility and suggested that NOL1 and NSUN4 gene polymorphisms might be a potential liquid biopsy biomarker for pediatric ALL. The gene discussed is NOP2; the disease is acute lymphoblastic leukemia.